Paragon 28 Looks to Scale for Next Phase of Growth
The company grew 19% in 2023 despite contending with supply chain constraints and could growth another 20% in 2024. Mar 04, 2024
Vericel’s MACI Arthro to Drive Growth for Years
The company's MACI revenues grew nearly 25% in 2023 and Vericel expects the launch of MACI Arthro in the third quarter of 2024. Mar 04, 2024
ATEC Thrives in Disrupted Spine Market
The company grew more than 37% in 2023 as its procedural solutions win over surgeons in a disrupted spine market. Mar 01, 2024
Stryker Talks Tidal Wave Opportunity for Total Ankle Replacement
We talked to Michael Rankin about Stryker's view of enabling technology in foot and ankle as well as future demand in the ASC. Feb 29, 2024
Treace Medical Foresees Extended Growth Runway
The company grew more than 30% in 2023 and added another $750 million to its already massive $5 billion total addressable market. Feb 29, 2024
Smith+Nephew’s Fix for Orthopedics Remains Work in Progress
The company's orthopedic sales grew in the mid-single-digits for 2023 but were hamstrung by supply constraints and headwinds in China. Feb 28, 2024
Enovis Set to Maintain Double-Digit Recon Growth in 2024
The company's orthopedic sales grew in the mid-teens for 2023 and is likely to be a $1 billion recon player in 2024. Feb 26, 2024
Globus Aims For Integration Steady State by Mid-2024
The company finished 2023 with reported sales growth over 50% as it works to integrate NuVasive and reach a steady state in June 2024. Feb 22, 2024
Joint Replacement Makes Up For Lost Time in 2023
Backlogged procedures drove much of the robust demand for joint replacement in 2023 but more durable tailwinds could also be taking hold. Feb 16, 2024
Zimmer Biomet Officially Enters Growth Era
Healthy end markets and a robust innovation pipeline drove mid-single-digit growth for the company in 2023. Feb 09, 2024
